Amanda Ribas Suspended 2 Years by USADA Prior to UFC Debut

By Tristen Critchfield Jan 10, 2018
Strawweight Amanda Ribas will have to wait a while before making her Octagon debut.

USADA announced Wednesday that the 24-year-old Brazilian has accepted a two-year suspension after testing positive for ostarine in an out-of-competition urine test conducted on June 7, 2017. Ostarine is listed as an anabolic agent and is banned at all times per the UFC’s Anti-Doping Policy.

Ostarine, also known as MK-2866 and Enobosarm, is a non-FDA approved selective androgen receptor modulator (SARM) that is illegally sold in the United States and worldwide as a performance-enhancing substance,” the USADA statement read. “Ostarine is not currently available as a prescription medication in any country, and its unauthorized use may carry serious side effects.”

Ribas’ sanction began on the date her positive sample was collected, meaning she won’t be eligible to return to active competition until June 2019. Ribas was scheduled to face Juliana Lima at “The Ultimate Fighter 25” finale on July 7 before being provisionally suspended. Ribas has compiled a 6-1 career mark while competing on the regional circuit in Brazil.

<h2>Fight Finder</h2>